Researchers found performing genetic testing of retinoblastoma patients followed by testing their at-risk family members might eliminate the need for additional testing in relatives and identify the few high-risk relatives who need intensive screening.
Related Articles on Ophthalmology:
Microvascular Changes in Retina Could be Early Warning Sign for Disability
Ophthalmologists Criticize Federal Review of Glaucoma Screening
American Academy of Ophthalmology CEO Urges Ophthalmologists to Fight Efforts to Expand Optometric Practice
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.